CDH2 and small cell lung carcinoma: The STXBP1 expression was also able to predict the recurrence of SCLC patients [AUC–receiver operating characteristic (ROC) = 0.922] compared to CDH2 (AUC–ROC = 0.633; Fig. S12D).